- Home
- TJX vs JNJ Comparison
TJX vs JNJ Comparison
Compare TJX & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TJX | JNJ |
|---|---|---|
| Founded | 1962 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.3B | 589.2B |
| IPO Year | 1994 | 2003 |
Fundamental Metrics
Financial Performance| Metric | TJX | JNJ |
|---|---|---|
| Price | $157.60 | $234.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 20 |
| Target Price | $169.00 | ★ $238.20 |
| AVG Volume (30 Days) | 3.8M | ★ 6.4M |
| Earning Date | 05-20-2026 | 04-14-2026 |
| Dividend Yield | 1.20% | ★ 2.18% |
| EPS Growth | 14.32 | ★ 90.50 |
| EPS | 4.87 | ★ 11.03 |
| Revenue | ★ $29,078,407,000.00 | N/A |
| Revenue This Year | $6.75 | $6.63 |
| Revenue Next Year | $5.81 | $7.24 |
| P/E Ratio | $32.94 | ★ $21.62 |
| Revenue Growth | ★ 6.04 | N/A |
| 52 Week Low | $119.84 | $146.12 |
| 52 Week High | $165.82 | $251.71 |
Technical Indicators
Market Signals| Indicator | TJX | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 47.38 | 40.01 |
| Support Level | $152.69 | $233.83 |
| Resistance Level | $163.70 | $246.40 |
| Average True Range (ATR) | 3.38 | 4.56 |
| MACD | -0.19 | -0.62 |
| Stochastic Oscillator | 27.64 | 17.20 |
Price Performance
Historical ComparisonAbout TJX TJX Companies Inc. (The)
Founded in 1987, TJX Companies is the world's largest off-price apparel and home fashions retailer, operating more than 5,000 stores across nine countries. In fiscal 2025, the company generated roughly $56 billion in sales. TJX operates through four segments: Marmaxx (61% of sales), HomeGoods (17%), TJX Canada (9%), and TJX international (13%). Its off-price model emphasizes branded merchandise at meaningful discounts, driving high traffic and rapid inventory turnover.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.